Literature DB >> 34271777

Distribution of High-risk Human Papillomavirus Genotypes in Cervical Secretions in Punjab.

Sadia Minhas1,2, Muhammad Kashif3, Zobaria Rehman4, Muhammad Bilal Pasha5, Muhammad Idrees6, Farheen Ansari2.   

Abstract

OBJECTIVE: To determine the high risk-human papillomavirus (HR-HPV) prevalence, genotype distribution, and associated risk factors in women with general gynaecological problems. STUDY
DESIGN: Descriptive, cross-sectional study. PLACE AND DURATION OF STUDY: Lady Wallingdon Hospital, Lahore from August 2018 to May 2019.
METHODOLOGY: One hundred females with general gynaecological problems constituted the sample. Real-time polymerase chain reaction and liquid base cytology were performed for HR-HPV detection, genotyping, and cytological changes in cervical samples.
RESULTS: The overall prevalence of HR-HPV was found to be 57%, with the most frequent HR-HPV genotypes HPV 16 (18%), HPV 18 (6%), and HPV 45 (1%). The total prevalence of single HR-HPV infection was 25%; whereas, multiple co-infection of HR-HPV was seen in 32% of cases. In total, 81% of these women had normal cytology and 19% had cytologic abnormalities. A significant association was observed between HR-HPV infection and general gynaecological complaints and between HR-HPV infection and cytological abnormalities (p < 0.001).
CONCLUSION: The HR-HPV prevalence was 57% with the most prevalent genotypes were HPV 16 and HPV 18. The results will also aid the identification of HR-HPV 51 and 31 genotypes, which should be added in the multi-type HPV vaccines. Key Words: Cancer of cervix, Human papillomavirus, Papanicolaou test, Pakistan.

Entities:  

Year:  2021        PMID: 34271777     DOI: 10.29271/jcpsp.2021.07.786

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  1 in total

1.  Risk factors of cervical cancer and role of primary healthcare providers regarding PAP smears counseling: Case control study.

Authors:  Halima Sadia; Irfan Murtaza Shahwani; Kiran Fatima Mehboob Bana
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.